Multistep Carcinogenesis: A Chain Reaction of Aneuploidizations
暂无分享,去创建一个
[1] O. Iversen. The skin tumorigenic and carcinogenic effects of different doses, numbers of dose fractions and concentrations of 7,12-dimethylbenz[a]anthracene in acetone applied on hairless mouse epidermis. Possible implications for human carcinogenesis. , 1991, Carcinogenesis.
[2] R. McAllister,et al. Tumorigenicity of Tissue Culture Cells , 1959 .
[3] A. Laat,et al. Carcinogenesis induced by UVA (365-nm) radiation: the dose-time dependence of tumor formation in hairless mice , 1997 .
[4] Nordling Co. A New Theory on the Cancer-inducing Mechanism , 1953 .
[5] W. Lijinsky. A view of the relation between carcinogenesis and mutagenesis , 1989, Environmental and molecular mutagenesis.
[6] Hongyue Dai,et al. Widespread aneuploidy revealed by DNA microarray expression profiling , 2000, Nature Genetics.
[7] B. Johansson,et al. A breakpoint map of recurrent chromosomal rearrangements in human neoplasia , 1997, Nature Genetics.
[8] H. Pilch,et al. Evaluation of DNA ploidy and degree of DNA abnormality in benign and malignant melanocytic lesions of the skin using video imaging , 2000, Cancer.
[9] Yudong D. He,et al. Gene expression profiling predicts clinical outcome of breast cancer , 2002, Nature.
[10] C. Boone,et al. Sarcomas routinely produced from putatively nontumorigenic Balb/3T3 and C3H/10T1/2 cells by subcutaneous inoculation attached to plastic platelets. , 1976, Journal of supramolecular structure.
[11] N. Fusenig,et al. Multiple stages and genetic alterations in immortalization, malignant transformation, and tumor progression of human skin keratinocytes , 1998, Molecular carcinogenesis.
[12] N. B. Atkin. Nuclear Size in Premalignant Conditions of the Cervix Uteri , 1964, Nature.
[13] H. Kacser,et al. The molecular basis of dominance. , 1981, Genetics.
[14] M. Fox. Fundamentals of Oncology , 1979, British Journal of Cancer.
[15] A. Zetterberg,et al. Cytomorphological grading and feulgen DNA‐analysis of metaplastic and neoplastic bronchial cells , 1978, Cancer.
[16] Jeffrey K. Cohen,et al. Origins and clinical implications of aneuploidy in early bladder cancer. , 1995, Cytometry.
[17] L. Donehower,et al. Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours , 1992, Nature.
[18] J. Davies,et al. Molecular Biology of the Cell , 1983, Bristol Medico-Chirurgical Journal.
[19] R. Hay. American Type Culture Collection catalogue of cell lines and hybridomas , 1985 .
[20] Richard D. Wood,et al. Human DNA Repair Genes , 2001, Science.
[21] F. McCormick. The polymerase chain reaction and cancer diagnosis. , 1989, Cancer cells.
[22] F. Mertens,et al. Karyotypic heterogeneity and clonal evolution in squamous cell carcinomas of the head and neck. , 2002, Cancer genetics and cytogenetics.
[23] N. B. Atkin,et al. Chromosome abnormalities as primary events in human malignant disease: evidence from marker chromosomes. , 1966, Journal of the National Cancer Institute.
[24] W. Giaretti. A model of DNA aneuploidization and evolution in colorectal cancer. , 1994, Laboratory investigation; a journal of technical methods and pathology.
[25] H. Ribbert,et al. Zur Frage der Entstehung maligner Tumoren , 1914, Naturwissenschaften.
[26] M. Hamou,et al. Cellular and tumoural heterogeneity of EGFR gene amplification in human malignant gliomas , 2005, Acta Neurochirurgica.
[27] B. Johansson,et al. Primary vs. secondary neoplasia‐associated chromosomal abnormalities—balanced rearrangements vs. genomic imbalances? , 1996, Genes, chromosomes & cancer.
[28] C. Nordling. A New Theory on the Cancer-inducing Mechanism , 1953, British Journal of Cancer.
[29] P. Duesberg,et al. Are Centrosomes or Aneuploidy the Key to Cancer? , 1999, Science.
[30] J. Cairns. The origin of human cancers , 1981, Nature.
[31] B. Li,et al. neu/ERBB2 cooperates with p53-172H during mammary tumorigenesis in transgenic mice , 1997, Molecular and cellular biology.
[32] R. Monson,et al. Breast cancer in women after repeated fluoroscopic examinations of the chest. , 1977, Journal of the National Cancer Institute.
[33] Allan Balmain,et al. Cancer genetics: from Boveri and Mendel to microarrays , 2001, Nature Reviews Cancer.
[34] A. Plaja,et al. Chromosome aneuploidy and cancer: lessons from a chromosomal instability syndrome. , 2001, Cancer genetics and cytogenetics.
[35] Robert A. Weinberg,et al. A checkpoint on the road to cancer , 1998, Nature.
[36] R. Goldsby,et al. Isolation and characterization of thymidine transport mutants of Chinese hamster cells. , 1969, Experimental cell research.
[37] T. Webb. When theories collide: experts develop different models for carcinogenesis. , 2001, Journal of the National Cancer Institute.
[38] L. S. Cram,et al. Spontaneous neoplastic evolution of Chinese hamster cells in culture: multistep progression of karyotype. , 1983, Cancer research.
[39] P. Duesberg,et al. Aneuploidy correlated 100% with chemical transformation of Chinese hamster cells. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[40] Jean Marx,et al. Debate Surges Over the Origins of Genomic Defects in Cancer , 2002, Science.
[41] R. Pollack,et al. Cancer biology. , 1978, Science.
[42] B. S. Baker,et al. Segmental aneuploidy and the genetic gross structure of the Drosophila genome. , 1972, Genetics.
[43] P. Duesberg,et al. Are cancers dependent on oncogenes or on aneuploidy? , 2003, Cancer genetics and cytogenetics.
[44] K. Kinzler,et al. The multistep nature of cancer. , 1993, Trends in genetics : TIG.
[45] F. D. de Gruijl,et al. Carcinogenesis induced by UVA (365-nm) radiation: the dose-time dependence of tumor formation in hairless mice. , 1997, Carcinogenesis.
[46] L. I. Gardner. Human Genetics: Problems and Approaches , 1981 .
[47] S. Goodman,et al. Evidence that genetic instability occurs at an early stage of colorectal tumorigenesis. , 2001, Cancer research.
[48] K. Kinzler,et al. Genetic instability in colorectal cancers , 1997, Nature.
[49] K. Brand,et al. Chromosomal Aberrations in Foreign Body Tumorigenesis of Mice 1 2 , 1983, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.
[50] P. Rous. Surmise and Fact on the Nature of Cancer , 1959, Nature.
[51] P. Gosling. DORLAND’S ILLUSTRATED MEDICAL DICTIONARY , 2003, Australasian Chiropractic & Osteopathy.
[52] Olufunmilayo I. Olopade,et al. The Chromosomes in Human Cancer and Leukemia , 1981 .
[53] L. Hayflick. THE LIMITED IN VITRO LIFETIME OF HUMAN DIPLOID CELL STRAINS. , 1965, Experimental cell research.
[54] A. Aguilera,et al. High levels of chromosome instability in polyploids of Saccharomyces cerevisiae. , 1990, Mutation research.
[55] G. Yarrington. Molecular Cell Biology , 1987, The Yale Journal of Biology and Medicine.
[56] H. Höfler,et al. Evaluation of C-ErbB-2 Overexpression and Her-2/neu Gene Copy Number Heterogeneity in Barrett’s Adenocarcinoma , 2000, Analytical cellular pathology : the journal of the European Society for Analytical Cellular Pathology.
[57] P. Armitage,et al. The Age Distribution of Cancer and a Multi-stage Theory of Carcinogenesis , 1954, British Journal of Cancer.
[58] T. Kunkel,et al. Effects of altered nucleotide concentrations on the fidelity of DNA replication. , 1985, Basic life sciences.
[59] P. Duesberg,et al. Specific aneusomies in Chinese hamster cells at different stages of neoplastic transformation, initiated by nitrosomethylurea , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[60] D. Kurnit. Down syndrome: gene dosage at the transcriptional level in skin fibroblasts. , 1979, Proceedings of the National Academy of Sciences of the United States of America.
[61] P. Duesberg,et al. Aneuploidy vs. gene mutation hypothesis of cancer: recent study claims mutation but is found to support aneuploidy. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[62] D. Bostwick,et al. Detection of c-myc oncogene amplification and chromosomal anomalies in metastatic prostatic carcinoma by fluorescence in situ hybridization. , 1997, Cancer research.
[63] E. Schröck,et al. Genomic changes defining the genesis, progression, and malignancy potential in solid human tumors: A phenotype/genotype correlation , 1999, Genes, chromosomes & cancer.
[64] J. Little,et al. Timing of the steps in transformation of C3H 10T½ cells by X-irradiation , 1984, Nature.
[65] N. Konishi,et al. Intratumor cellular heterogeneity and alterations in ras oncogene and p53 tumor suppressor gene in human prostate carcinoma. , 1995, The American journal of pathology.
[66] A. Balmain,et al. How many mutations are required for tumorigenesis? implications from human cancer data , 1993 .
[67] A. Levan,et al. Inverse relationship between chromosome ploidy and host-specificity of sixteen transplantable tumors☆ , 1953 .
[68] J. Bishop. Enemies within: the genesis of retrovirus oncogenes , 1981, Cell.
[69] L. Foulds. The experimental study of tumor progression: a review. , 1954, Cancer research.
[70] J. Scribner,et al. Tumor initiation and promotion. , 1978, International review of experimental pathology.
[71] K Wheatley,et al. The importance of diagnostic cytogenetics on outcome in AML: analysis of 1,612 patients entered into the MRC AML 10 trial. The Medical Research Council Adult and Children's Leukaemia Working Parties. , 1998, Blood.
[72] D. Hansemann. Ueber asymmetrische Zelltheilung in Epithelkrebsen und deren biologische Bedeutung , 1890, Archiv für pathologische Anatomie und Physiologie und für klinische Medicin.
[73] L. Old,et al. Transforming ras genes from human melanoma: a manifestation of tumour heterogeneity? , 1984, Nature.
[74] H. S. Thompson,et al. Dorland's Illustrated Medical Dictionary, 26th ed , 1982 .
[75] A. Cornish-Bowden. Kinetics of Multi‐Enzyme Systems , 2001 .
[76] Paul E Polani. The Role of Chromosomes in Cancer Biology , 1974 .
[77] M. Vogt,et al. A genetic change in a tissue culture line of neoplastic cells. , 1958, Journal of cellular physiology. Supplement.
[78] P. Walker. Cancer—Science and Society , 1980, British Journal of Cancer.
[79] S H Kim,et al. Transgenic mouse models that explore the multistep hypothesis of intestinal neoplasia , 1993, The Journal of cell biology.
[80] F T Bosman,et al. Intratumor genetic heterogeneity in advanced human colorectal adenocarcinoma , 2001, International journal of cancer.
[81] A. Bradley,et al. Embryonic lethality and tumorigenesis caused by segmental aneuploidy on mouse chromosome 11. , 1998, Genetics.
[82] Yuesheng Jin,et al. Clonal chromosome abnormalities in premalignant lesions of the skin. , 2002, Cancer genetics and cytogenetics.
[83] J. Ingle,et al. Centrosome hypertrophy in human breast tumors: implications for genomic stability and cell polarity. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[84] C. Epstein. The Consequences of Chromosome Imbalance: Principles, Mechanisms, and Models , 1986 .
[85] P. Duesberg,et al. Aneuploidy precedes and segregates with chemical carcinogenesis. , 2000, Cancer genetics and cytogenetics.
[86] L. Loeb,et al. Mutator phenotype may be required for multistage carcinogenesis. , 1991, Cancer research.
[87] P. Duesberg,et al. How aneuploidy affects metabolic control and causes cancer. , 1999, The Biochemical journal.
[88] Giovanni Parmigiani,et al. Prevalence of somatic alterations in the colorectal cancer cell genome , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[89] Harvey F. Lodish,et al. MOLECULAR.CELL.BIOLOGY 5TH.ED , 2003 .
[90] M. Stampfer,et al. Chromosome analyses of human mammary epithelial cells at stages of chemical-induced transformation progression to immortality. , 1989, Cancer genetics and cytogenetics.
[91] D. Haber,et al. The promise of cancer genetics , 1998, The Lancet.
[92] R. Stock,et al. The sigmoidal curve of cancer , 2003, Nature Biotechnology.
[93] P. Duesberg,et al. Explaining the high mutation rates of cancer cells to drug and multidrug resistance by chromosome reassortments that are catalyzed by aneuploidy. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[94] A. Böcking,et al. Diagnostic and prognostic value of DNA cytometry in gynecologic cytology. , 1989, Analytical and quantitative cytology and histology.
[95] D. Hanahan,et al. The Hallmarks of Cancer , 2000, Cell.
[96] International Human Genome Sequencing Consortium. Initial sequencing and analysis of the human genome , 2001, Nature.
[97] A. Sandberg,et al. Chromosome Alterations and Oncogenes in Human Neoplasia , 1990 .
[98] F. Waldman,et al. ERBB-2 (HER2/neu) gene copy number, p185HER-2 overexpression, and intratumor heterogeneity in human breast cancer. , 1995, Cancer research.
[99] M. Matzke,et al. Rapid structural and epigenetic changes in polyploid and aneuploid genomes , 1999, BioEssays : news and reviews in molecular, cellular and developmental biology.
[100] Robert A. Weinberg,et al. Creation of human tumour cells with defined genetic elements , 1999, Nature.
[101] B. Ponder,et al. Molecular Genetics of Cancer , 1992, Nature Medicine.
[102] C. Yue,et al. Genome-wide search for loss of heterozygosity using laser capture microdissected tissue of breast carcinoma: an implication for mutator phenotype and breast cancer pathogenesis. , 2000, Cancer research.
[103] A. Balmain,et al. Genetic changes in skin tumor progression: Correlation between presence of a mutant ras gene and loss of heterozygosity on mouse chromosome 7 , 1990, Cell.
[104] L. Franks. Neoplastic development , 1976, Nature.
[105] A. Meyers,et al. Identification of individuals at high risk for head and neck carcinogenesis using chromosome aneuploidy detected by fluorescence in situ hybridization. , 1999, Mutation research.
[106] William C Hahn,et al. Rules for making human tumor cells. , 2002, The New England journal of medicine.
[107] T. Hauschka. Correlation of chromosomal and physiologic changes in tumors. , 1958, Journal of cellular physiology. Supplement.
[108] Cori Bargmann,et al. Mechanism of activation of a human oncogene , 1982, Nature.
[109] W. Hahn,et al. Derivation of human tumor cells in vitro without widespread genomic instability. , 2001, Cancer research.
[110] P. Duesberg,et al. Aneuploidy, the somatic mutation that makes cancer a species of its own. , 2000, Cell motility and the cytoskeleton.
[111] F. Waldman,et al. Heterogeneity, polyploidy, aneusomy, and 9p deletion in human glioblastoma multiforme. , 1995, Cancer genetics and cytogenetics.
[112] D. Magennis. Nuclear DNA in histological and cytological specimens: measurement and prognostic significance. , 1997, British journal of biomedical science.
[113] Iscn. International System for Human Cytogenetic Nomenclature , 1978 .
[114] C. Purdie,et al. Tumour incidence, spectrum and ploidy in mice with a large deletion in the p53 gene. , 1994, Oncogene.
[115] Roger H. Reeves. Recounting a genetic story , 2000, Nature.
[116] P. Hieter,et al. Polyploidy--More Is More or Less , 1999, Science.
[117] I. Berenblum,et al. An Experimental Study of the Initiating Stage of Carcinogenesis, and a Re-examination of the Somatic Cell Mutation Theory of Cancer , 1949, British Journal of Cancer.
[118] T. Hassold. Chromosome abnormalities in human reproductive wastage , 1986 .
[119] P. Duesberg,et al. Latent viruses and mutated oncogenes: no evidence for pathogenicity. , 1992, Progress in nucleic acid research and molecular biology.
[120] R. Holliday. Chromosome error propagation and cancer. , 1989, Trends in genetics : TIG.
[121] J. Chin,et al. Relationship between DNA ploidy, glandular differentiation, and tumor spread in human prostate cancer. , 1985, Cancer research.
[122] W. Giaretti,et al. Intratumor heterogeneity of K-ras2 mutations in colorectal adenocarcinomas: association with degree of DNA aneuploidy. , 1996, The American journal of pathology.
[123] A. Reith,et al. Specific gain of chromosome 19 in preneoplastic mouse liver cells after diethylnitrosamine treatment. , 1991, Carcinogenesis.
[124] J. Barrett,et al. Chemically induced aneuploidy in mammalian cells: mechanisms and biological significance in cancer. , 1986, Environmental mutagenesis.
[125] K. Bayreuther. Chromosomes in Primary Neoplastic Growth , 1960, Nature.
[126] L. Sachs,et al. Identification of a chromosome that controls malignancy in chinese hamster cells , 1977, Journal of cellular physiology.
[127] S. Corsale,et al. DNA aneuploidy and high proliferative activity but not K‐ras‐2 mutations as independent predictors of clinical outcome in operable gastric carcinoma , 2001, Cancer.
[128] P. Carroll,et al. Heterogeneity of erbB-2 gene amplification in bladder cancer. , 1993, Cancer research.
[129] P. Duesberg,et al. Origin of multidrug resistance in cells with and without multidrug resistance genes: Chromosome reassortments catalyzed by aneuploidy , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[130] P. Nowell. The clonal evolution of tumor cell populations. , 1976, Science.
[131] C. Lengauer. How do tumors make ends meet? , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[132] P. Duesberg,et al. Aneuploidy versus gene mutation as cause of cancer , 2001 .
[133] F. Waldman,et al. Genomic instability is an early event during the progression pathway of ulcerative-colitis-related neoplasia. , 1999, The American journal of pathology.
[134] I. Weinstein. Addiction to Oncogenes--the Achilles Heal of Cancer , 2002, Science.
[135] Ian Tomlinson,et al. Selection, the mutation rate and cancer: Ensuring that the tail does not wag the dog , 1999, Nature medicine.
[136] H Knecht,et al. Centrosome defects and genetic instability in malignant tumors. , 1998, Cancer research.
[137] T J Horder,et al. The cells of the body: a history of somatic cell genetics , 1997, Medical History.
[138] P. Edwards,et al. Spectral karyotyping suggests additional subsets of colorectal cancers characterized by pattern of chromosome rearrangement , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[139] C. Keysser. Neoplastic Development, Vol. 2 , 1976 .
[140] J. Sudbø,et al. DNA content as a prognostic marker in patients with oral leukoplakia. , 2001, The New England journal of medicine.
[141] N. B. Atkin,et al. Are human cancers ever diploid--or often trisomic? Conflicting evidence from direct preparations and cultures. , 1990, Cytogenetics and cell genetics.
[142] D. Grimwade,et al. The predictive value of hierarchical cytogenetic classification in older adults with acute myeloid leukemia (AML): analysis of 1065 patients entered into the United Kingdom Medical Research Council AML11 trial. , 2001, Blood.
[143] Magennis Dp. NUCLEAR DNA IN HISTOLOGICAL AND CYTOLOGICAL SPECIMENS: MEASUREMENT AND PROGNOSTIC SIGNIFICANCE , 1997 .
[144] Christian A. Rees,et al. Microarray analysis reveals a major direct role of DNA copy number alteration in the transcriptional program of human breast tumors , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[145] F. Mitelman,et al. Genetic convergence and divergence in tumor progression. , 1988, Cancer research.
[146] P. Duesberg,et al. Genetic instability of cancer cells is proportional to their degree of aneuploidy. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[147] U. Ahlstrom. Chromosomes of primary carcinomas induced by 7,12-dimethylbenz(a)anthracene in the rat. , 1974, Hereditas.
[148] G. Barski,et al. Characteristics of "hybrid"-type clonal cell lines obtained from mixed cultures in vitro. , 1962, Journal of the National Cancer Institute.
[149] P. Blount,et al. Flow-cytometric and histological progression to malignancy in Barrett's esophagus: prospective endoscopic surveillance of a cohort. , 1992, Gastroenterology.
[150] N. B. Atkin,et al. Possible differences between the karyotypes of preinvasive lesions and malignant tumours. , 1969, British Journal of Cancer.
[151] P. Fialkow,et al. Clonal origin of human tumors. , 1979, Annual review of medicine.
[152] T. Hauschka. The chromosomes in ontogeny and oncogeny. , 1961, Cancer research.
[153] S. van der Flier,et al. Analysis of N-ras mutations in human cutaneous melanoma: tumor heterogeneity detected by polymerase chain reaction/single-stranded conformation polymorphism analysis. , 1995, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer.
[154] Thomas J. Liesegang,et al. Human DNA repair genes. Wood RD,∗ Mitchell M, Sgouros J, Lindahl T. Science 2001;291:1284–1289. , 2001 .
[155] B. Strauss. The origin of point mutations in human tumor cells. , 1992, Cancer research.
[156] A. Levan,et al. Specific chromosome changes in malignancy: studies in rat sarcomas induced by two polycyclic hydrocarbons. , 2009, Hereditas.
[157] L. S. Cram,et al. Karyotype instability of Chinese hamster cells during in vivo tumor progression , 1987, Somatic cell and molecular genetics.
[158] P. Duesberg,et al. Instability of chromosome structure in cancer cells increases exponentially with degrees of aneuploidy. , 2003, Cancer genetics and cytogenetics.
[159] R H Hruban,et al. Gene expression profiles in normal and cancer cells. , 1997, Science.
[160] E. Huberman,et al. Mutagenesis by chemical agents in V79 chinese hamster cells: a review and analysis of the literature. A report of the Gene-Tox Program. , 1981, Mutation research.
[161] M. Kimmey,et al. DNA aneuploidy in colonic biopsies predicts future development of dysplasia in ulcerative colitis. , 1992, Gastroenterology.
[162] H. Kacser,et al. MOlecular democracy: who shares the controls? , 1979, Biochemical Society transactions.
[163] E. Tajara,et al. Cytogenetic study of neoplastic and nonneoplastic cells of the skin. , 1995, Cancer genetics and cytogenetics.
[164] P. Duesberg,et al. Correspondence re: D. Zimonjic et al., Derivation of human tumor cells in vitro without widespread genomic instability. Cancer Res., 61: 8838-8844, 2001. , 2002, Cancer research.
[165] K. Loeb,et al. Multiple mutations and cancer , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[166] C Lengauer,et al. Genetic instability and darwinian selection in tumours. , 1999, Trends in cell biology.
[167] C. Harris,et al. Chemical and physical carcinogenesis: advances and perspectives for the 1990s. , 1991, Cancer research.
[168] L. Deaven,et al. On the nature of heteroploidy. , 1974, Cold Spring Harbor symposia on quantitative biology.
[169] S. Lippman,et al. Molecular markers of the risk of oral cancer. , 2001, The New England journal of medicine.
[170] K. Haigis,et al. Intestinal adenomas can develop with a stable karyotype and stable microsatellites , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[171] B. Strauss. The Stability of the Genome and the Genetic Instability of Tumors , 2000, Perspectives in biology and medicine.
[172] B. Brinkley,et al. Supernumerary centrosomes and cancer: Boveri's hypothesis resurrected. , 1998, Cell motility and the cytoskeleton.
[173] A. Hanby,et al. An inbred colony of oncogene transgenic mice: diversity of tumours and potential as a therapeutic model. , 1996, British Journal of Cancer.
[174] M. Gershwin,et al. Relationship between karyotype of tissue culture lines and tumorigenicity in nude mice. , 1984, Experimental cell biology.
[175] I. Purchase,et al. Reflections on the declining ability of the Salmonella assay to detect rodent carcinogens as positive. , 1988, Mutation research.
[176] I. Yaniv,et al. Molecular cytogenetic parameters in Ewing sarcoma. , 2003, Cancer genetics and cytogenetics.
[177] Y. Nakamura,et al. Genetic alterations during colorectal-tumor development. , 1988, The New England journal of medicine.
[178] J. Barrett,et al. Tumour promoters induce mitotic aneuploidy in yeast , 1981, Nature.
[179] F. Miller,et al. The cellular basis of tumor progression. , 1998, International review of cytology.
[180] B. Dutrillaux,et al. Near haploidy in breast cancer: a particular pathway of chromosome evolution. , 1998, Cancer genetics and cytogenetics.